Literature DB >> 11301210

Dopamine transporter-immunoreactive axons in the mediodorsal thalamic nucleus of the macaque monkey.

D S Melchitzky1, D A Lewis.   

Abstract

The reciprocal connections between the mediodorsal thalamic nucleus and the prefrontal cortex participate in a circuit that is essential to a number of higher cognitive processes. Projections from the dopamine-containing cells of the ventral mesencephalon to the prefrontal cortex are also critical for these cognitive abilities. It is unclear, however, whether dopamine axons innervate the mediodorsal thalamic nucleus in primates. In order to address this question, we examined the distribution of dopamine transporter-immunoreactive axons in the mediodorsal thalamic nucleus of macaque monkeys. Labeled axons were distributed quite heterogeneously in this nucleus, and did not strictly follow cytoarchitectonic subdivision boundaries. The ventral and lateral portions of the mediodorsal thalamic nucleus, which include parts of the parvicellular and multiform subdivisions, had the highest density of dopamine transporter-immunoreactive axons. In contrast, the dorsomedial portion, which included primarily the magnocellular subdivision, had the lowest density of labeled axons. In both lightly and densely innervated portions of the nucleus, small, dense clusters of dopamine transporter-immunoreactive axons were present. Axons immunoreactive for tyrosine hydroxylase were distributed in a pattern very similar to that of dopamine transporter-labeled axons. In contrast, noradrenergic axons, as revealed by dopamine beta-hydroxylase immunoreactivity, were present in higher density and were more evenly distributed throughout the mediodorsal thalamic nucleus. This dopamine innervation of the mediodorsal thalamic nucleus reveals another possible anatomical substrate through which dopamine may influence the cognitive functions mediated by thalamo-prefrontal circuitry.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11301210     DOI: 10.1016/s0306-4522(01)00021-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  The primate thalamus is a key target for brain dopamine.

Authors:  Miguel Angel Sánchez-González; Miguel Angel García-Cabezas; Beatriz Rico; Carmen Cavada
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

2.  Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating.

Authors:  Karen M Alsene; Abha K Rajbhandari; Marcia J Ramaker; Vaishali P Bakshi
Journal:  Neuropsychopharmacology       Date:  2011-01-19       Impact factor: 7.853

3.  Midbrain dopamine D2/3 receptor binding in schizophrenia.

Authors:  Heli Tuppurainen; Jyrki T Kuikka; Mikko P Laakso; Heimo Viinamäki; Minna Husso; Jari Tiihonen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

Review 4.  The mediodorsal thalamic nucleus and schizophrenia.

Authors:  Raúl Alelú-Paz; José Manuel Giménez-Amaya
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

5.  Thalamo-cortical dysfunction in cocaine abusers: implications in attention and perception.

Authors:  Dardo Tomasi; Rita Z Goldstein; Frank Telang; Thomas Maloney; Nelly Alia-Klein; Elisabeth C Caparelli; Nora D Volkow
Journal:  Psychiatry Res       Date:  2007-06-19       Impact factor: 3.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.